Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Anemia | D000740 | HP_0001903 | D64.9 | 11 | 103 | 128 | 68 | 50 | 352 |
Chronic renal insufficiency | D051436 | — | N18 | 8 | 24 | 27 | 10 | 19 | 87 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | 7 | 21 | 18 | 12 | 11 | 66 |
Neoplasms | D009369 | — | C80 | 1 | 14 | 14 | 5 | 11 | 45 |
Myelodysplastic syndromes | D009190 | — | D46 | 2 | 21 | 11 | 2 | 5 | 38 |
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 2 | — | 4 | 8 | 15 |
Lymphoma | D008223 | — | C85.9 | 1 | 3 | 7 | 1 | 2 | 14 |
Iron-deficiency anemia | D018798 | HP_0001891 | D50 | 1 | 2 | 3 | 4 | 5 | 14 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | 2 | 4 | 1 | 2 | 8 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 6 | 1 | — | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 16 | 3 | 1 | — | 4 | 22 |
Leukemia | D007938 | — | C95 | — | 5 | 7 | — | 1 | 13 |
Traumatic brain injuries | D000070642 | — | S06 | — | 5 | 4 | — | 1 | 8 |
Plasma cell neoplasms | D054219 | — | — | — | 2 | 5 | — | 1 | 8 |
Multiple myeloma | D009101 | — | C90.0 | — | 1 | 3 | — | 3 | 7 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 4 | 2 | — | 1 | 7 |
Cerebral palsy | D002547 | — | G80 | 1 | 2 | 1 | — | 3 | 7 |
Brain hypoxia-ischemia | D020925 | EFO_1000846 | P91.6 | 4 | 3 | 3 | — | — | 7 |
Acute kidney injury | D058186 | HP_0001919 | N17 | — | 4 | 2 | — | 2 | 7 |
Blood transfusion | D001803 | — | — | — | 4 | 5 | — | 1 | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | 5 | — | — | — | 5 |
Ischemic stroke | D000083242 | — | — | 3 | 2 | — | — | — | 4 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | 2 | 1 | — | — | 1 | 3 |
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | 2 | — | — | 1 | 3 |
Congenital heart defects | D006330 | HP_0001627 | Q24.9 | 1 | 2 | — | — | 1 | 3 |
Critical illness | D016638 | — | — | — | 2 | — | — | 1 | 3 |
Friedreich ataxia | D005621 | Orphanet_95 | G11.11 | — | 3 | — | — | — | 3 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | 1 | — | — | — | 2 |
Retinopathy of prematurity | D012178 | EFO_1001158 | H35.1 | 1 | 1 | — | — | 1 | 2 |
Reperfusion injury | D015427 | — | — | — | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | 2 | 3 |
Reticulocyte count | D017701 | — | — | 1 | — | — | — | — | 1 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | — | — | — | — | 1 |
Autoimmune hepatitis | D019693 | — | K75.4 | 1 | — | — | — | — | 1 |
Hypogonadism | D007006 | HP_0000044 | E23.0 | 1 | — | — | — | — | 1 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | — | — | — | — | 1 |
Alveolar bone loss | D016301 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetic retinopathy | D003930 | EFO_0003770 | — | — | — | — | — | 2 | 2 |
Surgical blood loss | D016063 | — | — | — | — | — | — | 2 | 2 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 2 | 2 |
Sepsis | D018805 | HP_0100806 | A41.9 | — | — | — | — | 2 | 2 |
Continuous ambulatory peritoneal dialysis | D010531 | — | — | — | — | — | — | 1 | 1 |
Developmental disabilities | D002658 | EFO_0003852 | F89 | — | — | — | — | 1 | 1 |
Iron metabolism disorders | D019189 | — | E83.1 | — | — | — | — | 1 | 1 |
Hemolytic anemia | D000743 | — | D55-D59 | — | — | — | — | 1 | 1 |
Vitamin b 12 deficiency | D014806 | EFO_0000734 | E53.8 | — | — | — | — | 1 | 1 |
Arthroplasty | D001178 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Epoetin zeta |
INN | epoetin alfa |
Description | Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. In these situations they decrease the need for blood transfusions. The different agents are more or less equivalent. They are given by injection.
|
Classification | Protein |
Drug class | erythropoietins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108593 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 64FS3BFH5W (ChemIDplus, GSRS) |